Xueying An
China Pharmaceutical University(CN)National Clinical Research Center for Digestive Diseases(CN)Anhui Academy of Agricultural Sciences(CN)Nanjing Drum Tower Hospital(CN)Shanghai Pesticide Research Institute(CN)National Clinical Research(US)Second Affiliated Hospital of Nanjing Medical University(CN)Beijing Children’s Hospital(CN)Pharmaceutical Biotechnology (Czechia)(CZ)State Key Laboratory of Pharmaceutical BiotechnologyNanjing University(CN)
Publications by Year
Research Areas
Osteoarthritis Treatment and Mechanisms, RNA Interference and Gene Delivery, Nanoplatforms for cancer theranostics, Mesenchymal stem cell research, Extracellular vesicles in disease
Most-Cited Works
- → Novel Gold Nanorod-Based HR1 Peptide Inhibitor for Middle East Respiratory Syndrome Coronavirus(2019)95 cited
- → In situ modification of ZIF-67 with multi-sulfonated dyes for great enhanced methylene blue adsorption via synergistic effect(2020)71 cited
- → Synthesis-temperature-regulated multi-enzyme-mimicking activities of ceria nanozymes(2021)66 cited
- → Synergistic Amplification of Oxidative Stress–Mediated Antitumor Activity via Liposomal Dichloroacetic Acid and MOF‐Fe2+(2019)58 cited
- → Ultrasound-responsive alkaline nanorobots for the treatment of lactic acidosis-mediated doxorubicin resistance(2020)40 cited
- → Enhanced SIRT3 expression restores mitochondrial quality control mechanism to reverse osteogenic impairment in type 2 diabetes mellitus(2025)29 cited